Home » Ivax Sees Final Approval for Generic Biaxin Filmtabs
Ivax Sees Final Approval for Generic Biaxin Filmtabs
The FDA has approved Ivax's abbreviated new drug application for clarithromycin tablets USP in 250-mg and 500-mg doses.
Clarithromycin is the generic version of Abbott's Biaxin filmtabs, an antibiotic used to treat mild-to-moderate infections. U.S. sales for clarithromycin tablets in 250-mg and 500-mg doses totaled $196.9 million for the 12 months ending March 2005, according to IMS Health data.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct